|
KMID : 0882420210960010013
|
|
Korean Journal of Medicine
2021 Volume.96 No. 1 p.13 ~ p.21
|
|
|
The Current Strategy of Helicobacter pylori Eradication
|
|
Kwon Yong-Hwan
|
|
|
Abstract
|
|
|
|
Helicobacter pylori (H. pylori) is the main cause of most gastroduodenal diseases. Triple therapy including two antibiotics, amoxicillin and clarithromycin, and a proton pump inhibitor given for a week has been recommended as the treatment of choice since the revision of the Korean H. pylori Clinical Practice Guidelines in 2013. However, antimicrobial resistance significantly decreased the cure rate of H. pylori eradication to 63.9%. Thus, the new H. pylori treatment regimen would be needed to increase the eradication rate in Korea. Recently, the update of clinical practice guideline for treatment of H. pylori was developed by conducting a meta-analysis. In this review, the recommended H. pylori eradication regimen in current 2020 guideline will be discussed.
|
|
|
KEYWORD
|
|
|
Helicobacter pylori, Drug resistance, Clarithromycin, Metronidazole
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|